Table 4.
The prevalence of isolated risk factors and proportion of individuals categorised as ‘high risk’ after age stratification
| Females (n = 474) | <45 years n = 126 | 45–49 years n = 132 | 50–54 years n = 110 | 55–59 years n = 72 | ≥ 60 years n = 34 |
|
| |||||
| Body mass index ≥30 kg/m2 | 27 (21.4) | 38 (28.8) | 33 (30.0) | 11 (15.3) b,c | 7 (20.6) |
| Body mass index 25–29.9 kg/m2 | 44 (34.9) | 45 (34.1) | 43 (39.1) | 29 (40.3) | 14 (41.2) |
| Total cholesterol ≥5.20 mmol/l | 22 (17.5) | 35 (26.5) | 44 (40.0) a,b | 33 (45.8) a,b | 16 (47.1) a,b |
| TC:HDL ratio ≥6 | 0 (0.0) | 4 (3.0) a | 4 (3.6) a | 3 (4.2) a | 1 (2.9) |
| Systolic blood pressure ≥140 mmHg | 7 (5.6) | 29 (22.0) a | 29 (26.4) a | 18 (25.0) a | 8 (23.5) a |
| Diastolic blood pressure ≥90 mmHg | 18 (14.3) | 28 (21.2) | 23 (20.9) | 10 (13.9) | 6 (17.6) |
| Current smoker | 12 (9.5) | 14 (10.6) | 12 (10.9) | 5 (6.9) | 3 (8.8) |
| QRISK2 ≥20% | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (2.8) | 0 (0.0) |
| Framingham Lipids ≥20% | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Framingham BMI ≥20% | 0 (0.0) | 1 (0.8) | 0 (0.0) | 2 (2.8) | 0 (0.0) |
| JBS2 ≥20% | 0 (0.0) | 1 (0.8) | 2 (1.8) | 4 (5.6) a,b | 3 (8.8) a,b |
|
| |||||
| Males (n = 316) | <45 years n = 89 | 45–49 years n = 98 | 50–54 years n = 68 | 55–59 years n = 42 | ≥ 60 years n = 19 |
|
| |||||
| Body mass index ≥30 kg/m2 | 27 (30.3) | 32 (32.7) | 21 (30.9) | 15 (35.7) | 8 (42.1) |
| Body mass index 25–29.9 kg/m2 | 41 (46.1) | 50 (51.0) | 36 (52.9) | 19 (45.2) | 8 (42.1) |
| Total cholesterol ≥5.20 mmol/l | 33 (37.1) | 40 (40.8) | 21 (30.9) | 23 (54.8)c | 7 (36.8) |
| TC:HDL ratio ≥6 | 22 (24.7) | 17 (17.3) | 14 (20.6) | 13 (31.0) | 3 (15.8) |
| Systolic blood pressure ≥140 mmHg | 11 (12.4) | 20 (20.4) | 11 (16.2) | 16 (38.1) a,b,c | 9 (47.4) a,b,c |
| Diastolic blood pressure ≥90 mmHg | 25 (28.1) | 33 (33.7) | 22 (32.4) | 13 (31.0) | 5 (26.3) |
| Current smoker | 20 (22.5) | 15 (15.3) | 8 (11.8) | 7 (16.7) | 2 (10.5) |
| QRISK2 ≥20% | 0 (0.0) | 2 (2.0) | 6 (8.8) a,b | 5 (11.9) a,b | 4 (21.1) a,b |
| Framingham Lipids ≥20% | 1 (1.1) | 4 (4.1) | 4 (5.9) | 12 (28.6) a,b,c | 5 (26.3) a,b,c |
| Framingham BMI ≥20% | 0 (0.0) | 6 (6.1) a | 10 (14.7) a | 14 (33.3) a,b,c | 13 (68.4) a,b,c,d |
| JBS2 ≥20% | 8 (9.0) | 10 (10.2) | 16 (23.5) a,b | 21 (50.0) a,b,c | 9 (47.4) a,b,c |
Data are represented as numbers and proportion of age group in brackets.
a
Denotes difference from <45-year age group (P<0.05).
b
Denotes difference from 45–49-year age group (P<0.05).
c
Denotes difference from 50–54-year age group (P<0.05).
d
Denotes difference from 55–59-year age group (P<0.05).